SVANBORG CATHARINA has a total of 25 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOINCEPT LLC, ZENSUN SHANGHAI SCIENCE AND TECHNOLOGY LTD and FARON PHARMACEUTICALS OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 | |
#6 | Sweden | 2 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Special foods | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes | |
#8 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Svanborg Catharina | 16 |
#2 | Svensson Malin Wilhelmina | 3 |
#3 | Mok Kenneth Hun | 2 |
#4 | Hakansson Per Anders | 2 |
#5 | Mossberg Ann-Kristin | 2 |
#6 | Sabharwal Hemant | 2 |
#7 | H Kansson Anders | 1 |
#8 | Malin Wilhelmina Svensson | 1 |
#9 | Trulsson Maria | 1 |
#10 | Petterson-Kastberg Jenny | 1 |
Publication | Filing date | Title |
---|---|---|
GB201505382D0 | Novel therapy | |
US2012028883A1 | Complex and production process | |
GB0900260D0 | Complex and production process | |
US2008039381A1 | Lactalbumin for Inhibiting Angiogenesis | |
GB0211658D0 | Novel therapies and methods of screening for therapeutic compounds | |
GB0210464D0 | Therapeutic treatment | |
GB0205347D0 | Biologically active complex | |
WO9926979A1 | Lactalbumin production process | |
GB9725126D0 | Therapeutic agents | |
GB9724725D0 | Protein production process | |
CA2188903A1 | Anti cancer therapy and compositions | |
SE9402437D0 | Pharmaceutical composition | |
SE9401433D0 | Anticancer composition |